Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
B. Riley Securities analyst Mayank Mamtani reiterates Harrow (NASDAQ:HROW) with a Buy and raises the price target from $70 t...
Lake Street analyst Thomas Flaten maintains Harrow (NASDAQ: HROW) with a Buy and raises the price target from $42 to $70.
HC Wainwright & Co. analyst Yi Chen reiterates Harrow (NASDAQ: HROW) with a Buy and maintains $64 price target.
BTIG analyst Thomas Shrader reiterates Harrow (NASDAQ: HROW) with a Buy and maintains $63 price target.
Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has ...
Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it ...
B. Riley Securities analyst Mayank Mamtani maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $65 to...
